(PharmaNewsWire.Com, January 26, 2024 ) Increased procurement to tackle terrorist strikes, border disputes, and sensitive multi-cultural issues
India is one of the fastest-growing economies in the world. It is also the eighth-largest in military expenditure and third-largest in armed forces in the world. In the past 10 years, India has grown its international influence and has become a prominent voice in global affairs. It has prioritized good relationships with Russia, France, the US, Israel, China, Iran, Japan, and several other countries in recent years. India is facing increasing instances of terrorist strikes, border disputes, sensitive multi-cultural issues, and rampant crime. These factors have led to the increased procurement of armored vehicles in the country, thereby fueling the growth of the Indian armored vehicles market.
In March 2021, the Ministry of Defence (MoD) awarded a major contract to Mahindra Defence Systems (MDS) for the manufacturing of armored tactical vehicles (specifically Light Strike Vehicles - LSV) for the Indian Army for its recce and weapon carrier requirements. The Mahindra Defence Systems LSV has undergone rigorous and elaborate trial procedures carried out by the Indian Army in different terrains, including high altitudes, deserts, and plains. It is the only vehicle that passed all field, ballistics, and technical trials.
Paramount Group, based in South Africa, is enlarging its manufacturing facility in India to diversify the array of combat vehicles it intends to manufacture. This expansion includes the incorporation of 4x4 and 6x6 infantry fighting platforms, extending the product lineup to cater to global customers. This expansion strengthens the already established industrial collaboration between the partners. In 2021, Paramount and Bharat Forge formalized a cooperative agreement for jointly manufacturing the Kalyani M4 armored personnel carrier in India. A substantial number of these vehicles have been supplied to the Indian Army under a contract valued at approximately USD 21.4 million.
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
